Ascendia

  MARKET NEWS

Gerresheimer Expands Collaboration With Portal Instruments for Commercialization of the PRIME Nexus Reusable Autoinjector
Amphista Therapeutics Discloses First Details of SMARCA2 Degrader Program
Roivant & Priovant Announce Positive Phase 3 Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis
Pneumagen Launches NeumoBind Technology Platform to Unlock New Opportunities in Intranasal Therapeutics
Rein Therapeutics Announces New Translational Data on its Novel Therapy for Idiopathic Pulmonary Fibrosis
Arch Strengthens its Position as a Leading Kidney Therapeutics Company With Acquisition of Breakthrough Platform to Develop New Drugs Targeting Chronic Kidney Disease
Sharp Invests $20 Million in Autoinjector & Pen Assembly Lines to Meet Rising Demand for Injectables
Osivax Announces First Participant Vaccinated in Phase 2b Trial Evaluating Broad-Spectrum Influenza A Vaccine Candidate
Terumo Blood & Cell Technologies Supports Expanded Access to Rare Disease Therapies in Latin America
Areteia Therapeutics Announces Positive Topline Results From First Phase 3 Study of Oral Dexpramipexole in Eosinophilic Asthma

  EXPERT CONTENT & RESOURCES

CAPMUL GDO (Glycerol Dioleate) is a Versatile Excipient for Pharmaceutical Formulations

CAPMUL GDO (Glycerol Dioleate) is a Versatile Excipient for Pharmaceutical Formulations

ABITEC is excited to present its latest excipient, CAPMUL GDO, Glycerol Dioleate.  CAPMUL GDO is a high-purity, highly versatile functional lipid

The Benefits of Transparent Pricing: How to Compare CMO Proposals & Know What Your True Costs Will Be

The Benefits of Transparent Pricing: How to Compare CMO Proposals & Know What Your True Costs Will Be

We want your experience as a pharmaceutical professional responsible for evaluating and selecting a CMO to be different. This article will help you be prepared when choosing a CMO from among multiple candidates.

Kindeva e-Book: A Bridge to the Future: Our World-Class Site in Bridgeton

Kindeva e-Book: A Bridge to the Future: Our World-Class Site in Bridgeton

In this e-Book, you will learn about, the integrated capabilities of Bridgeton, MO, which eliminate the risks of fragmentation, the breadth of projects that Kindeva can support, our continuous investment in the facility to ensure it meets today’s demands and the needs of tomorrow, and the benefits of partnering with Kindeva.

  FEATURED EDITORIAL

  COMPANY PROFILE

PharmaCircle is a leading provider of authoritative information, global insight, and expert analysis on the pharmaceutical, biotech, drug delivery technology and device, and animal health industries. PharmaCircle’s premier database tracks drugs, biologics and combination products in all stages of development, connecting pipeline and product information with formulation and component details.  The database delivers seamless integration of scientific, clinical, safety, regulatory, manufacturing and commercial information, and detailed analyses on over 9,000 drug delivery technologies and delivery devices. Click here for more.

  WHITEPAPERS & WEBINARS

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

In this talk we illustrate several case studies demonstrating how a fundamental understanding of molecular properties combined with a strategic vision for drug product design can lead to effective and advanceable formulations for even the most challenging drug products.

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

Watch this on-demand webinar to learn about the key steps and considerations in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages. Drawing from our 20 years of experience in the CDMO space, we cover critical topics unique to nanomaterials…..

  WHITEPAPERS & WEBINARS

WHITEPAPER - Drug Delivery – Recent Trends, Enabling Technologies, In-Vitro-In-Vivo Predictions & Personalized Medicine

WHITEPAPER - Drug Delivery – Recent Trends, Enabling Technologies, In-Vitro-In-Vivo Predictions & Personalized Medicine

By: Dr. Jens Morgenthaler, General Manager and Dr. Matthias Rischer, Head of Innovation, Losan Pharma GmbH

 Introduction

The successful formulation of small molecules is still one of the important challenges of today, especially if these drugs belong to the BioClassificationSystem …

WHITEPAPER - Container Selection for a Highly Sensitive Drug Product: A Success Story

WHITEPAPER - Container Selection for a Highly Sensitive Drug Product: A Success Story

Our client, a leading pharmaceutical company, came to us for a solution to a very specific problem. They needed a staked needle prefilled syringe (PFS) in a disposable auto-injector for their high-concentration monoclonal antibody product. These products are among the …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 24 – Analytical Testing
October 1 – Controlled Release